Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients

BACKGROUND: Patient‐derived organoid (PDO) models are highly valuable and have potentially widespread clinical applications. However, limited information is available regarding organoid models of non‐small cell lung cancer (NSCLC). This study aimed to characterize the consistency between primary tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jing‐Hua, Chu, Xiang‐Peng, Zhang, Jia‐Tao, Nie, Qiang, Tang, Wen‐Fang, Su, Jian, Yan, Hong‐Hong, Zheng, Hong‐Ping, Chen, Ze‐Xin, Chen, Xin, Song, Meng‐Meng, Yi, Xin, Li, Pan‐Song, Guan, Yan‐Fang, Li, Gang, Deng, Chu‐Xia, Rosell, Rafael, Wu, Yi‐Long, Zhong, Wen‐Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396373/
https://www.ncbi.nlm.nih.gov/pubmed/32633046
http://dx.doi.org/10.1111/1759-7714.13542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396373/
https://www.ncbi.nlm.nih.gov/pubmed/32633046
http://dx.doi.org/10.1111/1759-7714.13542

Ejemplares similares